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Introduction
Deposition of free immunoglobulin light chains (LC) 
within the kidney and the subsequent pathologic al-
terations that occur cause renal failure in slightly more 
than half of all patients with plasma cell dyscrasias 
(Gallo et al, 1989; Sanders et al, 1991; Sanders and 
Herrera, 1993). Renal failure can result from glomerular 
injury, proximal tubule damage, or cast nephropathy. In 
renal biopsies obtained from patients with LC-related 
renal diseases, LC are detected by electron microscopy 
within the glomerulus either as distinct granular osmio-
philic deposits associated with increased mesangial 
matrix (light chain deposition disease, LCDD) or as am-
yloid fibrils (light chain–related amyloidosis, AL-Am) re-
placing the normal mesangial matrix.
Although in patients with LCDD, a typical nodu-
lar glomerulopathy with formation of mesangial nod-
ules resulting from an increase in extracellular matrix 
material (ECM) eventually occurs, the opposite effect 
takes place in AL-Am, where the normal mesangium 
is destroyed and replaced by the amyloid fibrils. Tubu-
lar (T)-LC do not affect glomeruli. It has been proposed 
that proteolysis is an integral part of the process of 
amyloidogenesis. The current research was performed 
to elucidate the early events that take place as glo-
merulopathic (G)-LC contact mesangial cells (MC) with 
emphasis on signaling, internalization, and MC surface 
interactions.
MC are crucial in the pathogenesis of both of these 
processes. When cultured MC are exposed to mono-
clonal LC from LCDD patients, transforming growth 
factor (TGF)-β production is increased and extracellu-
lar matrix proteins (ECM) such as fibronectin, collagen 
iv, laminin, and tenascin accumulate. The increase in 
TGF-β inhibits mesangial proliferation and promotes 
ECM accumulation. Likewise, when LC obtained from 
patients with AL-Am are incubated with human mesan-
gial cells (HMC), amyloid formation occurs. These in vi-
tro changes mirror the alterations observed in vivo and 
suggest that the glomerulopathic changes induced in 
vivo are a function of the type of LC present. In con-
trast, T-LC do not alter mesangial homeostasis in vitro 
or in vivo (Herrera et al 1999).
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Abstract: Glomerulopathic monoclonal light chains (G-LC) interact with mesangial cells (MC), resulting in alterations of mesan-
gial homeostasis. Early signaling events control mitogenic activities and cytokine production, which in turn participate in the sub-
sequent pathologic events. Mesangial homeostasis is affected in two very different ways, depending on whether the G-LC is from 
a patient with light chain deposition disease (LCDD) or light chain–related amyloidosis (AL-Am). In contrast, tubulopathic (T)-LC 
chains from patients with myeloma cast nephropathy do not significantly interact with MC and result in no alterations in mesan-
gial homeostasis. Therefore, understanding early events in the monoclonal LC–MC interactions is fundamental. MC in culture were 
exposed to LC obtained and purified from the urine of patients with plasma cell dyscrasias and biopsy-proven renal disease, in-
cluding LCDD, AL-Am, and myeloma cast nephropathy. Incubation of MC with G-LC, but not T-LC, resulted in cytoskeletal and cell 
shape changes, activation of platelet-derived growth factor-β (PDGF-β) and its corresponding receptor, cytoplasmic to nuclear mi-
gration of c-fos and NF-κβ signals, and production of monocyte chemoattractant protein-1 (MCP-1), as well as increased expres-
sion of Ki-67, a proliferation marker. Although NF-κβ activation was directly related to MCP-1 production, c-fos activation regulated 
proliferative signals and cytoskeletal changes in MC. Amyloidogenic LC were avidly internalized by the MC, whereas LCDD-LC ef-
fector targets were located at the MC surface. These cellular events are likely initiated as a result of interactions of the G-LC with 
yet-uncharacterized MC surface receptors. Dissecting the events taking place when G-LC interact with MC may define potential 
important targets for selective therapeutic manipulation to ameliorate or prevent the glomerular injury that ensues.
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The entire sequence of events by which LC inter-
act with HMC to induce TGF-β production in LCDD and 
to lead to amyloidogenesis in AL-Am has not been en-
tirely elucidated. Short-term signaling events and long-
term effector mechanisms must take place to account 
for the initial and subsequent long-lasting alterations, 
respectively, that occur as G-LC interact with MC. In-
cubation of G-LC with MC causes pronounced cellular 
membrane ruffling within minutes. Concomitantly, ul-
trastructural immunogold labeling revealed that the 
G-LC interacted with the MC membrane via structures 
morphologically resembling clathrin-coated pits initiat-
ing signaling events that ultimately result in transmis-
sion of cytoplasmic signals to the MC nuclei to gener-
ate translational activities associated with activation of 
growth factors (Abboud, 1993; Herrera et al, 1994; Zhu 
et al, 1995). Although internalization is not an impor-
tant event in LCDD-LC–MC interactions, in AL-Am ear-
lier studies have shown that internalization and en-
dolysosomal processing of the LC is a prerequisite for 
amyloid formation (Tagouri et al, 1996). This would 
suggest that a receptor at a binding site exists on the 
MC surface for the internalization of LC in AL-Am and 
to initiate cell-signaling events resulting in the ECM ex-
pansion observed in LCDD. It is also possible that these 
processes, the internalization of LC in AL-Am and the 
ECM expansion in LCDD, are mediated by different LC 
receptors. The process of binding of different LC to the 
MC surface was examined by flow cytometry to char-
acterize LC–MC interactions. Signaling mechanisms in-
volved in LC–MC interactions were also explored in an 
attempt to determine whether there were any differ-
ences among G-LC and T-LC, and between LCDD and 
amyloid-producing LC.
MC have been determined to be among the cell 
types that can produce MCP-1 (Duque et al, 1997; 
Rovin et al, 1995, 1999; Ruiz-Ortega et al, 1998; Styl-
ianou et al, 1999). The intracellular signals that reg-
ulate MCP-1 expression in response to exogenous 
stimuli are not completely characterized. However, 
previous studies have demonstrated that activation of 
the transcription factor NF-κβ is necessary for interleu-
kin-1 (IL-1)-induced MCP-1 expression (Richards et al, 
1999; Rovin et al, 1999). Mitogenic stimuli, such as the 
platelet-derived growth factor-β (PDGF-β)–mediated ef-
fect on MC on exposure to G-LC documented to occur 
early in the “in-vitro” system and by the localization of 
PDGF-β in mesangial areas in biopsy specimens (Her-
rera et al, 1994), activate the ribosomal S6 kinase 1 
(RSK1) through the pathway involving the extracellular 
signal-regulated kinase (ERK) subfamily of mitogen-ac-
tivated protein (MAP) kinases. RSK plays an important 
role in nuclear signaling by phosphorylating various 
transcription factors, including c-fos, and is also im-
plicated in cell-cycle regulation (Richards et al, 1999). 
PDGF has also been shown to induce ruffling in fibro-
blasts (Mellström et al 1988). This suggests a role for 
c-fos in signaling events controlling MC proliferation 
and cytoskeletal actin rearrangement leading to sur-
face ruffling. The role of transcription factors such as 
NF-κβ and c-fos in MC interacting with G-LC was also 
explored.
Results
Testing of Purified LC for Endotoxins
No gelation was observed when all purified LC used in 
the present study at a concentration of 1 mg/ml were 
assayed, indicating the absence of endotoxins at the 
sensitivity limit dictated by the methodology. Positive 
and negative controls tested as expected with detect-
able endotoxin levels at 0.125 to 100 EU/ml in the pos-
itive control specimens and no gelation with negative 
controls.
Binding of LC to HMC
The binding of a LCDD-LC (And), and AL-LC (Hac), and 
a T-LC (Jon) to HMC in normal RPMI 1640 was exam-
ined at room temperature and at 37° C, pH 7.4. After a 
30- or 90-minute incubation period, a small increase in 
the percentage of FITC gated fluorescent cells was de-
tected only after the addition of the LCDD-LC to HMC 
(Figure 1). No increase in the percentage of gated R-PE 
fluorescent cells was detected when the AL-LC, or the 
T-LC were added to HMC (Figure 1). The binding of 
LCDD-LC to HMC was actually slightly more at 37° C 
than at room temperature.
LC binding was subsequently examined at 25° 
C and 37° C after the RPMI had been acidified to pH 
5.0 to inhibit clathrin-mediated endocytosis of LC. Un-
der these conditions, the increase in the percentage of 
gated cells binding either of the two G-LC, And or Hac, 
was substantially higher than that for the T-LC, Jon 
(Figure 2). When LC were incubated with HMC at 4° C 
or in medium made hypertonic with 250 mm sucrose, 
a slight increase in percentage of gated cells to which 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Light chain (LC) binding to mesangial cells (MC) 
at pH 7.4. Flow cytometry. Control, tubulopathic (T)-LC and 
amyloidogenic (AL)-LC show no significant binding to MC at 
pH 7.4. In contrast, light chain deposition disease (LCDD)-LC 
binds to MC at pH 7.4 as demonstrated in the right lower gate 
(quadrant), of the LCDD-LC flow cytometry chart.
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the G-LC, And or Hac, were bound was detected as 
compared with the T-LC, Jon. These conditions, which 
should have also disrupted clathrin-mediated uptake of 
LC, were not as effective in increasing the amount of 
LC bound to HMC as acidification of the cytosol.
The binding of LC to fetal HMC, mouse fibroblasts 
(L) cells, and Chinese hamster ovary (CHO) cells was 
compared at pH 7.4 and pH 5.0 to examine the speci-
ficity of the binding of the AL-LC, Hac, to these differ-
ent cell lines. As observed for adult HMC, acidification 
of the medium resulted in a dramatic increase in the 
percentage of gated R-PE fluorescent that could be de-
tected after addition of Hac to fetal HMC (Figure 3). In 
contrast, acidification of the medium produced a mar-
ginal increase in the percentage of R-PE fluorescent 
cells for L cells, and minimal if any change in binding 
to CHO cells (Figure 3).
Direct Fluorescence Microscopy
MC incubated with G-LC exhibited striking surface ruf-
fling associated with prominent cytoskeletal actin reor-
ganization, as detected when stained with Texas red-
phalloidin. Approximately 20% and 10% of all the MC 
exposed to G-LC (LCDD and AL-LC), respectively, ex-
hibited ruffling and cytoskeletal actin reorganization 
(Figs. 4, A to C, and 5) with maximum effect noted at 
40 to 45 minutes. The number of MC with ruffling in-
creased as time of incubation with G-LC was prolonged 
up to approximately 45 minutes. MC incubated with al-
bumin did not show surface ruffling or significant actin 
reorganization. HMC incubated with T-LC showed ruf-
fling in less than 1% of the cells.
Ultrastructural Studies
Surface ruffling was identified in an average of 18% 
of MC incubated with either LCDD or AL-LC. In con-
trast, less than 1% of MC incubated with albumin or 
T-LC showed evidence of surface ruffling. Ruffling was 
at first noted circumferentially in the MC within 20 to 
30 minutes after the initial application of G-LC (LCDD 
and AL-LC), and in approximately 60 to 90 minutes the 
surface ruffling became localized to focal cellular areas 
Figure 2. Light chain binding to MC at pH 5 (inhibition of 
clathrin-mediated endocytosis). Flow cytometry. Am (AL)-LC 
are detected at the MC surface when clathrin-mediated endo-
cytosis is inhibited at pH 5. There is also a significant increase 
in detectable LC at the MC surface in LCDD-LC, but not as 
dramatic as with the Am (AL)-LC, and no significant increase 
is noted for the T-LC.
Figure 3. Am (AL)-light chain interactions with other cell types at pH 5. Flow cytometry. Note that the interaction of Am (AL)-LC 
is rather specific with MC and does not occur with L or CHO cells. Interaction with fetal MC (left panel) are also shown and mim-
ics the results observed with adult human mesangial cells (HMC). L, mouse fibroblasts; CHO, Chinese hamster ovary.
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(Figure 6, A and B). Dense areas with accumulation of 
filaments consistent with actin were noted underneath 
the areas of ruffling once the surface alterations be-
came localized to focal areas in the MC (Figure 6B).
NF-κβ 65p and c-fos Immunolocalization in HMC
In HMC in culture, NF-κβ and c-fos were detected dif-
fusely in the cytoplasm (Figure 7, A and E). No nu-
clear fluorescence staining was noted. On exposure to 
G-LC (10 μg/ml), but not T-LC, the NF-κβ and c-fos sig-
nals disappeared from the cytoplasm, migrating to the 
nuclei within 20 minutes of exposure to the LC, indi-
cating redistribution of the signaling molecules. The 
nuclear signal was detected in 20% to 30% of MC in-
cubated with LCDD-LC (Figure 7, B and F). In contrast, 
less than 10% of MC reflected the cytoplasmic to nu-
clear migration of the NF-κβ signal and c-fos signals 
when incubated with AL-LC (Figure 7, C and G). Inter-
estingly, migration of c-fos (but not NF-κβ) from cyto-
plasm to nucleus occurred in the same cells with cyto-
skeletal actin reorganization and ruffling. Furthermore, 
when MC were exposed to T-LC at the same LC concen-
tration, the NF-κβ and c-fos signals remained in a cyto-
plasmic location (Figure 7, D and H). Only in very rare 
MC (much less than 1% of all MC), the NF-κβ and c-fos 
signals were detected in nuclei (p < 0.05).
Western Analysis of Nuclear Protein Extracts for 
NF-κβ 65p in HMC
Distinct bands corresponding to NF-κβ 65p were dem-
onstrated by Western analysis in the nuclear extracts 
of HMC treated with LCDD (And), AL (Bel, Hac), and 
T-LC (Jon) at 6 and 12 hours after application of LC. 
The intensity of the band with the LCDD-LC was more 
pronounced than that noted with the AL-LC and T-LC. 
The NF-κβ 65p bands obtained in the nuclear extracts 
of AL-LC–treated HMC were more distinct than those 
noted with the T-LC or media alone at the same time 
frame. Those findings are consistent with the results 
noted using immunofluorescence techniques monitor-
ing translocation of NF-κβ signals from cytoplasm to 
nuclei of HMC on exposure to LC. The intensity of the 
bands noted in HMC incubated with media alone at 0, 
6, and 12 hours were similar to the band seen with the 
T-LC (Figure 8).
MCP-1 Measurements in HMC Cultures
HMC exposed to LCDD-LC (And) showed the highest 
MCP-1 concentrations at 3, 6, and 12 hours after LC 
application when compared with media, AL-LC (Bel), 
T-LC (Jon), and BSA. Samples treated with AL-LC also 
showed increased MCP-1 concentrations as compared 
with media and T-LC (p < 0.05), but always less than 
LCDD-LC–treated samples (p < 0.05). MCP-1 concen-
trations in specimens treated with T-LC were similar to 
those in HMC in media alone with no LC at 3, 6, and 12 
hours after application (Table 1).
Tumor Necrosis Factor-α Measurements in HMC
Tumor necrosis factor (TNF)-α was below 8 (the level 
of detection of the ELISA test) in all experimental and 
control specimens, including those in which HMC were 
incubated with LCDD, AL-LC, and T-LC for 3, 6, 12, 24, 
and 48 hours, as well as in control samples incubated 
with media alone with no LC for the same times.
Figure 4. Texas red-phalloidin fluorescence stain. Early cy-
toskeletal changes in MC incubated with G-LC. A, B, and C, 
Sequential alterations in the F-actin distribution in the cyto-
skeletal framework of MC. Original magnification, A, ×500; B, 
×500; C, ×500.
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Immunohistochemistry Staining for Ki-67 Nu-
clear Antigens Associated with Proliferation
The percentage of Ki-67–positive nuclei in HMC was 
calculated in each of the experimental conditions and 
compared with untreated HMC (with media alone). Re-
sults are shown in Table 2. At all time frames, HMC in-
cubated with LCDD-LC had the highest percentage of 
Ki-67 staining cells, followed by those treated with AL-
LC. HMC treated with T-LC had a proliferation rate sim-
ilar to those incubated with no LC (media alone). As 
expected, HMC incubated with PDGF-BB (a growth fac-
tor known to stimulate MC proliferation) had the high-
est of all the Ki-67 counts. The percentage of Ki-67–
positive HMC increased from 1 to 24 hours, with the 
highest percentages detected at 24 hours in all exper-
imental conditions (Table 2). Incubation with anti-c-fos 
before LCDD-LC stimulation decreased Ki-67 staining 
of HMC by approximately half (p < 0.05). MC surface 
ruffling was decreased similarly. A similar but slightly 
less pronounced decrease in Ki-67 staining and MC cy-
toskeletal changes was noted when MC were preincu-
bated with anti-c-fos before PDGF-BB stimulation (p < 
0.05). The differences in Ki-67 staining and surface ruf-
fling in HMC preincubated with anti-c-fos before AL-LC 
and T-LC stimulation were not statistically significant. 
(Table 3, Figure 9).
Immunohistochemical Staining for PDGF-β, 
PDGF-β Receptor, and TGF-β
The most intense staining for PDFG and PDFG-β re-
ceptor was noted at 1 day, whereas the most intense 
staining for TGF-β was observed at 3 days after LC ap-
plication, at a time when the staining for PDGF-β and 
the corresponding receptor was much decreased when 
compared with the peak staining at 24 hours. PDGF-β 
and PDGF-β receptor staining correlated as expected 
(Figure 10). Negative and positive controls stained ac-
cordingly. Antigen-excess experiments abolished stain-
ing in MC, as expected. Avidin-biotin blocking experi-
ments further assured the specificity of the staining in 
MC for PDGF-β, PDGF-β-receptor, and TGF-β.
Discussion
MC play a pivotal role in the propagation and progres-
sion of tissue injury in monoclonal light chain-related 
glomerulopathies (Herrera et al, 1999) and other glo- 
Figure 5. Texas red-phalloidin fluorescence stain. Note that only some MC alter their cytoskeletal appearance when exposed to 
G-LC. Also noted circumferential ruffling that occurs after the initial changes depicted in Figure 4. Original magnification, ×350; 
insert, ×500.
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merular diseases (Abboud, 1991). LC–MC interactions 
are crucial in the pathogenesis of monoclonal LC-re-
lated renal diseases. The binding of the LCDD-LC to 
HMC at room temperature and pH 7.4, although in 
small quantities, emphasized the MC surface inter-
actions that occur with this type of G-LC. Actin reor-
ganization and surface ruffling was noted in approxi-
mately 20% and 10% of MC incubated with G-LC, 
either LCDD or AL-LC, respectively, whereas similar al-
terations were not seen in MC incubated with albumin, 
emphasizing that interactions between LC and MC take 
place. In contrast, T-LC induced ruffling in less than 1% 
of the MC. In previous work using immunoelectron mi-
croscopic techniques, LCDD-LC were shown to be in-
timately associated with the MC surface and localized 
to areas in the MC membrane ultrastructurally resem-
bling clathrin-coated pits (Zhu et al, 1995). Internaliza-
tion of the LCDD-LC was followed by rapid lysosomal 
degradation.
In contrast, no surface interactions could be de-
tected when AL-LC were incubated with MC at room 
temperature or at 37° C and pH 7.4. It seemed plausi-
ble to theorize that if AL-LC were internalized, a clath-
rin-mediated process might be involved. To test this, 
LC were incubated with HMC under a variety of condi-
tions (4° C, hypertonic medium, acidified medium) to 
disrupt clathrin-mediated internalization. Of these ap-
proaches, the acidification of the medium to pH 5.0 re-
sulted in the largest increase in the percentage of the 
gated population to which LC was bound.
The increase in binding to HMC was observed only 
for those LC that were glomerulopathic, the LCDD-LC 
(at room temperature and 37° C, pH7.4) and the AL-LC 
(under acidified pH 5 conditions), and that are known 
to interact with HMC in vivo and in vitro. The acidifica-
tion of the medium to pH 5.0 did not increase the bind-
ing of the myeloma cast nephropathy T-LC. The rela-
tive specificity of the binding of G-LC to HMC under 
acidified conditions is reflected in the inability of the 
AL-LC to bind to CHO cells and the small binding of the 
Hac (AL)-LC to L cells, a mouse fibroblast cell line. The 
binding of Hac to L cells probably is related to the sim-
ilar mesodermal derivation of these two cell types. MC 
are modified smooth muscle cells and these two cell 
lines may share a common receptor.
The exact identity of the putative HMC-LC receptor 
is under investigation and currently is unknown. Re-
ceptors for immune complexes have been described 
on MC (López-Armada et al, 1996) enabling them to 
phagocytose immune complexes. The fact that short-
term (signaling) events occur as LC interact with MC, 
such as the cytosolic to nuclear relocalization of signal-
ing molecules (c-fos and NF-κβ), further supports the 
existence of a receptor-mediated mechanism as part of 
these G-LC-MC interactions. Batuman and colleagues 
have identified cubilin as a high-capacity, low-affinity 
receptor for LC that can mediate their endocytosis in 
renal proximal tubule cells (Batuman and Guan, 1997; 
Batuman et al, 1998). This protein belongs to the low-
density lipoprotein (LDL) family of receptors. A com-
mon feature of this family of receptors is the ability to 
function as a multiligand receptor and bind multiple li-
gands with varying affinities at different sites. Cubilin 
contains at least 35 potential binding domains and, in 
addition to LC, is also capable of binding lysozyme, in-
sulin, cytochrome c, myoglobin, and β2-microglobulin. 
Whether cubilin is expressed by HMC is unknown. Al-
though cubilin represents the predominant receptor 
for LC on proximal tubule cells, other receptors may 
be present as well. The pattern of increased mesangial 
matrix components similar to that observed in diabetic 
nephropathy suggests that certain LC could bind to MC 
via the receptor for advanced glycosylation end-prod-
ucts (AGE). Yan et al (2000) have shown that RAGE (re-
ceptor for advanced glycosylation end-products) is a 
Figure 6. Transmission electron microscopy; uranyl acetate 
and lead citrate. The circumferential MC ruffling becomes lo-
calized to specific surface areas approximately 60 to 90 min-
utes after exposure of MC to G-LC. Underneath the focal areas 
of ruffling, actin accumulation occurs (arrow). Original magni-
fication, A, ×7,500; B, ×10,500.
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Figure 7. A to H, Fluorescence Texas red. Left panels, c-fos; Right panels, FN-κβ staining. A and E, Unstimulated MC with cy-
toplasmic distribution of NF-κβ (left) and c-fos (right). On exposure to LCDD-LC, NF-κβ and c-fos become redistributed from cy-
toplasm to nuclei (B and F). Likewise, on exposure to AL-LC a similar redistribution of NF-κβ and c-fos was noted; however, the 
number of MC showing redistribution is significantly less (C and G). When HMC was exposed to T-LC, the NF-κβ and c-fos re-
mained in a cytoplasmic location and did not migrate to the nuclei (D and H). Note that MC with nuclear c-fos expression appear 
rounded and show surface ruffling. Original magnification, ×350.
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receptor for the amyloidogenic form of serum amyloid 
A in a mononuclear phagocytic cell line. This hypoth-
esis is supported by the fact that approximately 20% 
to 30% of LC isolated from patients with monoclonal 
LC-related renal diseases are glycosylated. The activa-
tion of the yet-uncharacterized receptor in MC results 
in increased ECM via long-term events resulting from 
PDGF-β activation followed by TGF-β production follow-
ing a pattern of growth factor activation similar to that 
that has been seen in the in vitro model of LCDD-LC–
mediated mesangial injury (Herrera et al, 1999). Sim-
ilarly, in biopsy specimens, expression of these two 
growth factors has also been documented (Herrera et 
al, 1994). It is unclear at present whether the putative 
receptors for LC on MC are specific or shared by other 
effector molecules. Likewise, it is unknown whether 
LCDD and AL-LC use the same or a different receptor.
The lack of effect for T-LC on mesangial matrix ho-
meostasis is consistent with studies examining the 
binding of T-LC to proximal tubule cells. Batuman and 
colleagues used a pH 5.0 isotonic saline solution to re-
move membrane-bound T-LC (Batuman et al, 1998). 
Thus, an inherent difference appears to exist in the (af-
finity) ability of G- and T-LC to bind to HMC, and this 
difference most likely reflects amino acid differences 
within the variable region of individual LC. The ability 
of certain LC to interact differently with target cells un-
derscores their selective pathogenic potential for spe-
cific nephron sites and thus provides an explanation for 
their glomerulopathic versus tubulopathic properties.
The present study also highlights the importance of 
internalization in the pathogenesis of amyloidogene-
sis. Only when internalization is blocked can the AL-LC 
be demonstrated on the MC surface, emphasizing that 
the delivery of AL-LC to intracellular compartments for 
processing is a crucial component in their pathogen-
esis. In contrast, the surface interactions play a key 
role in the case of LCDD-LC, resulting in the binding 
of these LC to putative MC receptors to trigger intra-
cellular events that lead to increased transcription of 
matrix protein genes. Kon and colleagues have dem-
onstrated a functional interaction between two early-
intermediate transcription factors, NF-κβ and SMAD, 
to activate the expression of an ECM-related gene, 
COL7A1 (Kon et al 1999). It can be hypothesized from 
this data that a similar combined effect involving 
NF-κβ and TGF-β through SMAD may regulate the ex-
pression of other ECM-related genes in LCDD, account-
ing for the increase in ECM that is characteristic of this 
condition (Kon et al, 1999; Lawrence, 1995; Ponce-
let and Schnaper, 1998; Sharma and Ziyadeh, 1993; 
Whitman, 1998). In AL-Am, the accentuated MMP ef-
fect on the ECM, perhaps a direct effect of the amy-
loid deposition, predominates, resulting in a decrease 
in ECM. Amyloid may also exert a negative feedback 
on long-term effects.
It was demonstrated in the present study that sig-
naling mechanisms are activated when LCDD-LC con-
tact MC. NF-κβ and c-fos migrate quickly (within 
minutes) from their normal cytoplasmic location to 
assume nuclear expression as a crucial component 
of the signaling cascade. MCP-1 production by HMC 
when exposed to G-LC occurs concomitantly. There 
was no effect on TNF-α production by MC when stimu-
lated with the different LC. NF-κβ is found normally in 
the cytoplasm of MC as a dimer of p50 and p65 sub-
units bound to the inhibitory protein Iκβ. On stimula-
tion of MC by LC, Iκβ is released from the dimer, re-
sulting in migration of the p50-p65 complex to the 
nucleus and subsequent DNA binding. Although migra-
tion of c-fos and NF-κβ also occurred when AL-LC in-
teracted with HMC, this signaling pathway was not as 
effective as in the case of LCDD-LC-MC interactions. 
The degree of activation of NF-κβ in the different ex-
perimental conditions correlated directly with the level 
of production of MCP-1 by HMC. Furthermore, the ki-
netics of NF-κβ activation correlates with MCP-1 pro-
duction by MC. Translocation to the nucleus of active 
NF-κβ and binding to specific DNA sequences on NF-κβ 
response genes, such as MCP-1, RANTES, and ICAM-1, 
can lead to their enhanced transcription and genera-
tion. Analysis of the promoter region of human MCP-1 
has demonstrated several putative binding sites for 
transcription-activating factors, including recognition 
elements for NF-κβ. NF-κβ activation appears to be a 
necessary requirement for chemokine induction. It is 
interesting that the effect of AL-LC on NF-κβ is not as 
marked as in the case of LCDD-LC, perhaps an addi-
tional indication of divergent mechanisms at play in 
LCDD and AL-Am. Although activation of NF-κβ plays 
a central role in MC signaling activation (Massy et al, 
1999), it is not clear if key downstream events, such 
as TGF-β production by MC leading to progressive re-
nal damage (Kopp et al, 1996; Zhu et al, 1995), are 
also controlled directly by NF-κβ activation. NF-κβ 
could be stimulated through a phosphotyrosine ki-
nase signaling mechanism as proposed by Rovin et 
al (1995); however, this is not accepted universally 
(Kopp et al, 1996). The reduction in Ki-67 expression 
in HMC pretreated with anti-c-fos antibody before in-
cubation with G-LC, especially LCDD-LC, suggests that 
Figure 8. NF-κβ detection in nuclear preparations of MC at 
baseline (C0), 6 hours (C6), after exposure to IL-1 and a Jurkat 
cell lysate as positive controls (6 hours), and on exposure to 
two AL-LC (Hac and Bel), a LCDD-LC (And), and a T-LC (Jon) at 
6 hours. Note that the LCDD-LC shows the most intense band 
(similar to that of IL-1) followed by AL-LC (Hac and Bel). T-LC 
band is about the same intensity as control MC at the same 
time frame (6 hours) indicated as C6.
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c-fos signaling may be important in regulating the 
PDGF-β–driven mitogenic stimuli in HMC. Furthermore, 
c-fos likely mediates cytoskeletal rearrangement in 
MC through PDGF-β activation. Induction of membrane 
ruffling on human fibroblasts by PDGF has been docu-
mented previously(Mellström et al, 1988).
Further characterization of these receptor-mediated 
interactions has the potential to lead to a conceptual 
framework capable of serving as a basis for design-
ing new therapeutic interventions. Currently, the ther-
apeutic armamentarium available to treat these mono-
clonal LC-related renal disorders is limited to treating 
the clone of neoplastic plasma cells responsible for the 
production of the pathogenic LC. Progression to renal 
failure is the rule in these conditions since even small 
amounts of certain G-LC may result in continued re-
nal damage that eventually becomes irreversible. In-
terventions aimed at crucial events responsible for the 
pathogenic effects of G-LC on glomeruli must be de-
signed to prevent irreversible renal damage. Regulat-
ing NF-κβ activation may prove of value in preventing 
MC activation and early cytokine production, as has 
been suggested by some in vitro studies (Auwardt et 
al, 1998; Ishikawa et al 1999). Likewise, TGF-β could 
be a target for therapeutic intervention in LCDD (Au-
wardt et al, 1998; Border et al, 1992; Böttinger et al, 
1997; Feige and Baird, 1995; Ishikawa et al, 1999; Lip-
kowitz et al, 1996; Peters et al, 1998; Satriano and 
Schlondorff, 1994). In contrast, activation of c-fos ap-
pears to play a crucial role in the generation of prolifer-
ative/mitogenic and cytoskeletal signals in MC.
Conclusions
Signaling mechanisms mediated through NF-κβ and c-
fos are responsible for short-term effects of G-LC on 
HMC resulting in the production of MCP-1 and cellular 
proliferation and cytoskeletal rearrangement, respec-
tively. Interruption of these short-term effects may or 
may not result in subsequent alterations of the long-
term phenomena responsible for the pathologic alter-
ations that occur in glomeruli of patients with LCDD 
or AL-Am. Understanding the intricacies of the mecha-
nisms involved in LC-MC interactions may be important 
to identify potential targets for selective therapeutic 
intervention through modulation or complete abroga-
tion of specific pathways involved in glomerular injury.
Materials and Methods
LC Purification from Urine
The immunoglobulin LC used in this study were purified 
by affinity chromatography from the urine of patients 
with renal biopsy-proven myeloma cast nephropa-
thy (T-LC), LCDD, or AL-Am (G-LC). In essence, immu-
noglobulin LC were purified from the urine in stan-
dard fashion using ammonium surface precipitation 
Table 1. MCP-1 Concentrations in Supernatant of HMCs Incubated with and without LCs
Post-application            Media                                                                                                                                   1L-1
time frame (h)               alone                         T-LC                             AL-LC                          LCDD-LC                    control
     3  1767  1571  1604  2150  9912
     6   1961  3943  4264
   12  2683  2885  5251  6547
MCP-1, monocyte chemoattractant protein-1; HMCs, human mesangial cells; LCs, light chains; T-LC, tubulopathic light chain; AL-
LC, amyloidogenic light chain; LCDD-LC, light chain deposition disease light chain; IL-1, interleukin-1.
Table 2. Percentage of Ki-67 Staining in HMCs Incubated with and without LCs and PDGF-BB
Media                                                                                                                                                                 PDGF-BB
Time (h)                     No LC                          LCDD-LC                     AL-LC                        T-LC                             No LC
  1  10.5  16.7  14  9.8  28
  3  12  20.5  17  10  30
  6  15  22  18  11  33
24  17  25  22  13  34
PDGF-BB, platelet-derived growth factor-BB.
Table 3. Percentage of Ki-67 Staining in HMCs with and without Pretreatment with Anti-c-fos before Incubation 
with LCs and PDGF-β
Media                                                                                                                                                      PDGF-BB
Time (h)                                    No LC                LCDD-LC                   AL-LC                    T-LC                   No LC
    6  – c-fos  14  20  19  13  30
 + c-fos  12  8  17  12  19
  24  – c-fos  17  22  20  15  34
 + c-fos  18  11  16  14  19
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Figure 9. Ki-67 staining of MC with (right panel) and without (left panel) preincubation with anti-c-fos and subsequently incu-
bated with various LC and PDGF-BB as indicated. A and B, Incubated with LCDD-LC; C and D, incubated with PDGF-BB; E and F, 
incubated with AL-LC; and G and H, incubated with T-LC. Note, by comparing A, B, C, and D (LCDD- and PDGF-BB-treated cells), 
that c-fos preincubation reduced by approximately half the number of Ki-67 positive cells. The difference between E and F (AL-
LC) is not as noticeable. In contrast, the number of Ki-67–positive cells is rather small in G and H, corresponding to MC treated 
with T-LC. Original magnification, ×160.
 Monoclonal light chain–Mesangial cell inteRactions 699
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and ion exchange, as described previously (Sanders et 
al, 1987). Affinity chromatography consisted of pass-
ing urine over Sepharose CL-4B columns to which ei-
ther goat antihuman λ or antihuman κ antibodies 
had been conjugated. Free plus bound λ or κ LC were 
eluted from the columns with 0.1 m glycine, pH 2.2. 
The purity of the LC was checked on immunodiffusion 
plates and anti-IgG and anti-IgA affinity columns were 
used to remove contaminating IgG and IgA. When pu-
rified, the LC migrates as a single band when resolved 
by zone electrophoresis on agarose gels using a 50 
mm barbital buffer, pH 8.6, and consists entirely of ei-
ther free λ or κ LC as determined by immunofixation. 
Purified LC were concentrated, dialyzed against 0.9% 
NaCl, filtered through a 0.2-m membrane, and stored 
aseptically at 1 mg/ml at 4° C. The following nephro-
toxic LC were purified: And, a κ LCDD-LC; Mat, a κ AL-
LC; Hac and Bel, two λ AL-LC; and Jon, a λ T-LC from a 
patient with myeloma cast nephropathy. The purified 
LC had the same composition as those circulating in 
the serum. The LC proteins were selected to highlight 
that LC class does not necessarily dictate effects re-
sulting from LC–MC interactions. Furthermore, due to 
limited availability, not all LC were used in all exper-
iments. The LC employed in the various experiments 
were carefully chosen, depending on the question to 
be addressed.
Testing of Purified LC for Endotoxins
All LC preparations were tested for endotoxins using 
the Limulus amebocyte assay (Charles River Endosafe, 
Charleston, South Carolina). Briefly, endotoxin content 
is semiquantitated by mixing a kit reagent (amebo-
cyte lysate) with test sample or endotoxin standards 
and observing for gelation after incubation for 60 min-
utes at 37° C. If gelation occurs, it indicates that there 
is an amount of endotoxin in the sample that equals 
or exceeds the reagent’s labeled sensitivity (0.125 EU/
ml, a negligible amount). Appropriate positive controls 
with a 0.125 to 100 EU/ml range were also tested con-
comitantly, as well as negative controls with a 0.015 to 
0.0625 EU/ml range. An additional negative water con-
trol and positive product control spiked with 2 λ CSE 
were also tested.
HMC Culture
Primary cultures of adult HMC isolated as out-growths 
from glomerular remnants were obtained from ne-
phrectomy specimens following Harper’s methodology 
(Harper et al, 1984). Briefly, the renal cortex from un-
involved areas of kidneys removed for renal cell carci-
noma was cut into a fine mince (approximately 1-mm 
cubes). This mince was successively passed over stain-
less steel meshes of 300, 250, and 150 μm pore size. 
Glomeruli retained by the 150-μm mesh were incu-
bated for 30 minutes at room temperature with occa-
sional agitation in Ca+2/Mg+2 containing HBSS to which 
was added 750 U/ml collagenase. Following the colla-
genase digestion, glomeruli were allowed to settle out, 
the supernatant was removed, and the glomeruli re-
suspended in fresh HBSS. This rinse step was repeated 
twice. The clean glomerular sediment obtained was re-
suspended in RPMI 1640 medium at 37° C and buff-
ered with 25 mm HEPES at pH 7.4 and supplemented 
with 20% FBS, 100 U/ml penicillin, 100 μg/ml strep-
tomycin, 5 μg/ml bovine insulin, 5 μg/ml transferrin, 
5 ng/ml sodium selenite, 0.4 μg/ml hydrocortisone, 2 
mm glutamine, and 1 mm sodium pyruvate. Glomer-
ular remnants and HMC isolated from them were con-
tinuously cultured at 37° C, 5% CO2, and 92% relative 
humidity. The glomeruli were plated out on 100-mm2 
plates. After 7 days, outgrowths of MC from the glo-
merular remnant were detected and by 21 days the 
MC had begun to overgrow the epithelial cell contami-
nant. The MC were serially passaged four times to en-
sure a homogenous population. These cells were de-
termined to be a homogenous population of MC based 
on immunocytochemistry and ultrastructural evalua-
tion. HMC were negative for cytokeratin, CD45 (com-
mon leukocyte antigen), and Factor VIII antigens, but 
expressed smooth muscle actin and vimentin. These 
immunocytochemical reactions characterized the cells 
as MC and not epithelial, endothelial, or monocytic 
cells. Ultrastructurally, the cells showed myofilaments 
with spindle densities and attachment plaques indi-
cating their smooth muscle characteristics. Passage 5 
to 6 HMC grown to confluence in 25-mm2 flasks using 
high serum RPMI were used in this study. Two days be-
fore use in the experimental studies, the FBS content 
of the medium was reduced to 0.5% to render the cells 
quiescent.
Binding Studies
Monoclonal LC purified from the urine of patients with 
myeloma cast nephropathy (T-LC, Jon), LCDD (And), 
and AL-Am (Hac and Bel) were added to low serum 
(0.5% FBS) RPMI at 10 mg/ml. These LC were individ-
ually added to quiescent adult HMC in 25-mm2 flasks 
and LC binding was assessed at 25° C, 37° C, and 4° 
C, and again at 25° C and 37° C after the medium 
Figure 10.  PDGF-β, PDGF-β receptor, and TGF-β staining 
in HMC incubated with LCDD-LC and media alone (baseline). 
PDGF-β and its corresponding receptor staining peaked at 24 
hours post-incubation, highlighting the early activation of this 
growth factor when MCs are exposed to G-LC. Note also that 
TGF-β staining peaked late at 72 hours post-incubation of MCs 
with G-LCs.
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was made acidic (pH 5.0) or hypertonic with the addi-
tion of acetic acid (10 mm) or sucrose (0.45 m) to the 
medium. After a 30-minute incubation under these 
conditions, the flasks were quickly rinsed three times 
under the same conditions and with the same me-
dium as in the initial incubation to remove unbound 
LC. LC binding to HMC was detected by adding either 
goat F (ab’)2 antihuman (R-PE conjugate), or κ (FITC 
conjugate) antibodies to the same low serum RPMI 
medium as before (normal, acidic, or hypertonic) and 
incubating with HMC at the same temperature as be-
fore (25° C or 4° C) for an additional 15 minutes in 
the absence of LC. The flasks were then rinsed twice 
with cold FACS buffer (2% FBS, 0.1% NaN3 in PBS) to 
remove excess antibody. Cold glass beads and FACS 
buffer (2 ml) were added to each flask and the HMC 
were removed from the flask with gentle agitation by 
rolling the glass beads around the flasks at 4° C. Vi-
sual examination of the flasks using a phase contrast 
microscope revealed nearly complete harvesting of 
MC attached to the flasks. The HMC cell suspension 
obtained was centrifuged at 1,000 rpm for 10 minutes 
at 4° C. The HMC cell pellet was resuspended in 130 
ml of FACS buffer and 150 ml of 2% formaldehyde in 
PBS and fixed on ice for 15 minutes. The fixed cells 
were centrifuged as before and resuspended in 1 ml 
FACS buffer. After a final centrifugation, the cell pellet 
was resuspended in 300 ml of FACS buffer and placed 
on ice until LC binding to the HMC was assessed as 
membrane fluorescence with a FACS Vantage cytome-
ter. In another series of experiments LC binding to fe-
tal HMC (Clonetics, San Diego, California), mouse fi-
broblasts, L, and Chinese hamster ovary epithelial 
cells was examined under normal (pH 7.4) and acid-
ified (pH 5.0) conditions as previously described for 
adult HMC.
Direct Fluorescence Microscopy
Direct fluorescence staining following standard proce-
dures (Valenzuela and Deodhar, 1986) and using Texas 
red-phalloidin to study MC cytoskeletal F-actin distribu-
tion was performed to identify if surface or cytoskele-
tal actin alterations occurred associated with incuba-
tion of MC with G and T-LC.
MC grown on glass cover slips or chambered glass 
slides were first fixed at room temperature for 5 min-
utes with 20% formaldehyde in PBS and then fur-
ther fixed/permeabilized at -20° C for 5 minutes with 
methanol containing 1% formaldehyde. A similar fixa-
tion protocol was used before staining mesangial cells 
for Ki-67, c-fos, NK-κβ, PDGF-β, PDGF-β receptor, and 
TGF-β. MC incubated either without or with AL and 
LCDD-G and T-LC (10 ug/ml) were stained with Texas 
red-phalloidin (Molecular Probes, Eugene, Oregon) us-
ing a direct fluorescence method. Control MC were 
only incubated with albumin and no LC. MC were then 
analyzed using fluorescence microscopy with an Olym-
pus BX60 fluorescence microscope (C. Squared Com-
pany, Tamarac, Florida) to identify whether changes in 
the distribution of actin within the cytoskeleton and/or 
surface ruffling were present.
Ultrastructural Evaluation
Specimens for ultrastructural evaluation were fixed 
in Carson-Millonig solution (Polysciences, Warrington, 
Pennsylvania), embedded in epoxy resin (Poly-
sciences), and thick sectioned for light microscopic 
survey. The specimens included MC incubated with al-
bumin as control, LCDD, AL, and T-LC. Toluidine blue–
stained sections were used to select areas for prepa-
ration of thin sections. Once appropriate areas were 
identified, thin sections for ultrastructural evaluation 
were prepared. Thin sections were stained with uranyl 
acetate and lead citrate (Fisher Scientific, Pittsburgh, 
Pennsylvania). The specimens were examined with a 
Philips CM 10 transmission electron microscope (N.V. 
Philips, Eindhoven, The Netherlands). The percentage 
of MC with surface ruffling was calculated.
Immunolocalization of c-fos and NF-κβ p65 in LC-
Treated and Untreated HMC
HMC grown on 18-mm coverslips and fixed as de-
tailed previously were incubated with 10 μg/ml of var-
ious LC (And-LCDD-LC, Mat, Bel-AL-LC, or Jon T-LC) in 
low serum (0.5% FBS) RPMI 1640 for 20 minutes. MC 
in medium alone served as a negative control. After 
20 minutes, the cells were fixed at room temperature 
for 5 minutes with 2% formaldehyde in PBS. The cells 
were then permeabilized at -20° C for 5 minutes with 
methanol containing 1% formaldehyde. The cellular 
distribution of c-fos and NF-κβ p65 (cytosolic versus 
nuclear) was then assessed by immunofluorescence. 
HMC were incubated with a 10-fold dilution of rabbit 
polyclonal antibody to either c-fos (sc-52; Santa Cruz 
Biochemicals, Santa Cruz, California) or human NF-κβ 
p65 (sc-109, Santa Cruz) for another 1 hour at room 
temperature. The antibodies were diluted into PBS 
containing 0.25% BSA and 0.1% saponin before 300 
μl of diluted antibody solution was added to each cov-
erslip. A 200-fold dilution of a Texas red conjugated 
goat antirabbit polyclonal antibody (Jackson Immu-
noResearch, West Grove, Pennsylvania) was used to 
detect the distribution of the corresponding antigenic 
determinants detected within the MC. After 1 hour in-
cubation at room temperature, the secondary anti-
body was rinsed off, the coverslips mounted on glass 
slides, and the cellular distribution in HMC of c-fos 
and NF-κβ visualized with an Olympus BX60 fluores-
cence microscope.
Western Analysis of Nuclear Protein Extracts for 
NF-κβ 65p in HMC
And (LCDD-), Bel (AL-), Hac (AL-), and Jon (T)-LC (10 
μg/ml) were added to confluent HMC growing in 100-
mm dishes. HMC in medium alone or to which 10 μg/
ml BSA was added served as negative controls. Af-
ter 0.5, 1, 2, 4, 6, and 12 hours, the HMC were tryp-
sinized and a nuclear protein extract was obtained as 
described by Schreiber et al (1989). Briefly, trypsin-
ized HMC were pelleted, resuspended in 500 μl of hy-
potonic buffer A (10 mm HEPES, pH 7.9, 10 mm KCl, 
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0.1 mm EDTA, 0.1 mm EGTA, 1 mm DTT, and 0.5 mm 
PMSF) and allowed to swell on ice for 15 minutes. 
Ten percent Nonidet NP-40 was then added to buffer 
A to a final concentration of 0.5% and the cells were 
lysed by vortexing for 10 seconds. After centrifuging 
the lysate for 30 seconds in a centrifuge at 12,000 
×g, a nuclear pellet was obtained that was extracted 
for protein by vortexing the pellet with 50 μl of high 
salt buffer B (20 mm HEPES, pH 7.9, 400 mm NaCl, 
1 mm EDTA, 1 mm EGTA, 1 mm DTT, 1 mm PMSF) 
for 15 minutes at 4° C. Insoluble nuclear debris was 
then pelleted by centrifugation at 12,000 ×g in a mi-
crofuge for 5 minutes and the supernatant contain-
ing extracted nuclear proteins was carefully removed. 
The protein content of the extracts was determined 
by the BCA assay (Pierce, Rockford, Illinois). Twenty 
micrograms of total protein per well were loaded for 
each sample and the nuclear proteins resolved by 
SDS-PAGE on 3% to 8% polyacrylamide gels (Novex, 
San Diego, California) at 200v for 50 minutes using 
an SDS tris-acetate buffer. The resolved proteins were 
then transferred electrophoretically to PVDF mem-
branes at 10v for 3 hours. The PVDF membranes were 
blocked with 1 mg/ml BSA in TBS containing 0.1% 
Tween-20 (blocking buffer). The membranes were an-
alyzed for NF-κβ content using 0.5 μg/ml of a mouse 
anti-NF-κβ monoclonal antibody to human NF-κβ p65 
as primary antibody, a horseradish peroxidase conju-
gated goat antirabbit polyclonal antibody, 1:100,000 
dilution (Jackson ImmunoResearch) as the second-
ary antibody, and Pierce’s SuperSignal West Dura Ex-
tended Duration chemiluminescent substrate. A Jurkat 
(J) cell lysate and IL-1 were used as positive controls 
for detection of NF-κβ p65.
MCP-1 Measurements in HMC
ELISA plates (Costar, Cambridge, Massachusetts) 
were coated with 100 μl of monoclonal antibody to 
human MCP-1 (3.3 μg/ml; Endogen, Woburn, Massa-
chusetts) in 0.1 mm sodium carbonate buffer (pH 9.6) 
and incubated overnight at 4° C. After coating, the 
ELISA plates were washed once (4 minutes) with 200 
μl of PBS containing 0.05% Tween 20 (wash buffer). 
All subsequent washes were performed similarly. The 
plates were then blocked using 200 μl PBS-Tween 20 
containing 3% (w/v) BSA (Sigma Chemical, St. Louis, 
Missouri) as a blocking buffer for 2 hours at room 
temperature. After blocking, the plates were washed 
three times before use. All subsequent steps were 
performed in blocking buffer. One hundred microliters 
of diluted conditioned media from experimental sam-
ples (diluted at least 1:20 in blocking buffer) or stan-
dards (7.8–500 pg/ml) was incubated overnight at 4° 
C. Plates were washed four times and incubated with 
100 μl of biotinylated polyclonal antibody to MCP-1 
(500 ng/ml; Pharmingen, San Diego, California) for 2 
hours at room temperature. Plates were washed three 
times and then incubated with streptaviding-horse-
radish peroxidase (1:5,000; Poly-Strep-HRP, Endogen, 
Woburn, Massachusetts) for 30 minutes at room tem-
perature. After washing, 100 μl TMB substrate (Bio-
Rad, Hercules, California) was added and incubated 
for 15 minutes. The reaction was stopped with 100 μl 
of 0.1 n sulfuric acid and read at 450 nm using an 
ELISA plate reader (Cayman Chemical, Ann Arbor, 
Michigan).
TNF-α Measurements in HMC
ELISA plates (CoStar) were coated with 100 μl of 
monoclonal antibody to human TNFα (3.5 μg/ml; En-
dogen) to 10 mm PBS (pH 7.4) and incubated over-
night at 4° C. After coating, the ELISA plates were 
washed once (4 minutes) with 200 μl PBS contain-
ing 0.05% Tween 20 (wash buffer). All subsequent 
washes were performed similarly. The plates were 
then blocked using 200 μl PBS-Tween 20 containing 
3% (w/v) BSA (Sigma Chemical) as a blocking buffer 
for 2 hours at room temperature. After blocking, the 
plates were washed three times before use. All sub-
sequent steps were performed in blocking buffer. One 
hundred microliters of diluted conditioned media (di-
luted 1:5 in blocking buffer) from experimental sam-
ples or standards (3.9 to 500pg/ml) was incubated for 
1 hour at room temperature. After incubation, 50 μl 
of biotinylated monoclonal antibody (500 ng/ml; En-
dogen) in blocking buffer was added and incubated 
for another 1 hour at room temperature. Plates were 
washed 4 times and then incubated with PolyStrep-
HRP (1:5000; Endogen) for 30 minutes at room tem-
perature. After washing, 100 μl TMB substrate (Bio-
Rad) was added and incubated for 15 minutes. The 
reaction was stopped with 100 μl of 0.1 n sulfuric acid 
and read at 450 nm using an ELISA plate reader (Cay-
man Chemical).
Immunohistochemistry Staining for Ki-67 Nu-
clear Antigens Associated with Proliferation
HMC grown on coverslips and fixed as previously de-
tailed were stained using the avidin-biotin technique 
according to Hsu et al (1981). The monoclonal anti-
body to Ki-67 (Clone MMI) from Ventana Medical Sys-
tems was used prediluted and the staining proce-
dure was performed on the Ventana ES Automated 
Slide Stainer. HMC were placed on low serum me-
dia 48 hours before incubation with PDGF-BB (posi-
tive control), or no LC-media alone (negative control) 
LCDD, AL or T-LC. The overall number of MC per plate 
was similar as assessed by their confluency and cell 
counting. The number of Ki-67–positive nuclei was 
counted before and 1, 3, 6, and 24 hours after the 
addition of the LC. At least 150 HMC were counted 
in each experimental condition. The percentage of 
positive HMC nuclei was calculated. A group of HMC 
also grown on coverslips were pretreated with an an-
tibody to c-fos (sc-52; Santa Cruz; 200-fold dilution, 
final concentration 1 μg/ml) for 20 minutes before in-
cubation with LCDD, AL- or T-LC, and without LC (me-
dia alone).
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Immunohistochemistry Staining of HMC for 
PDGF-β, PDGF-β Receptor, and TFG-β
HMC grown on coverslips and fixed as previously de-
tailed were stained using the avidin-biotin complex 
technique according to Hsu et al (1981). The mouse 
monoclonal antibodies for PDGF-β and PDGF-β recep-
tor (Genzyme, Cambridge, Massachusetts) were used at 
1:150 dilution. The antibody for TGF-β detection was a 
rabbit polyclonal antibody (R and D Systems, Minneapo-
lis, Minnesota) used at a dilution of 1:100. Negative con-
trols were generated by replacing the primary antibody 
with nonspecific rabbit IgG. Avidin-biotin blocking was 
performed to ensure that all endogenous biotin recep-
tors or avidin sites present in the samples were blocked 
before the addition of the avidin reagent. The blocking 
consisted of applying 20 ml of avidin D followed by 20 
ml of biotin before incubation with the primary antibody 
to PDGF-β, PDGF-β receptor, and TGF-β. To determine 
that the staining was specific for the growth factor or 
receptor tested, antigen excess (four times equimolar 
amounts) was mixed with the corresponding antibody 
and then the mixture was applied to the coverslips.
The staining method is outlined below. Briefly, cov-
erslips were rinsed three times in 20 mm phosphate 
buffer, pH 7.4, and fixed in 80% ethanol for 15 min-
utes. After fixation, the coverslips were rinsed again 
three times with phosphate buffer, incubated in phos-
phate buffer containing 1.5% normal goat serum (Vec-
tor Laboratories, Burlingame, California) at 4° C for 10 
minutes, and incubated with primary antibody at the 
indicated dilution for 12 hours at 37° C. Unbound an-
tibody was aspirated and the cells were rinsed three 
times with phosphate buffer. Coverslips were incu-
bated with biotinylated goat antirabbit or antimouse 
IgG, depending on the antibody used (Vector Labora-
tories). After rinsing three times with phosphate buf-
fer, 0.1% diaminobenzidine tetrahydrochloride in 0.1 
m Tris buffer, pH 7.2, with 0.02% hydrogen peroxide 
was applied as the substrate of horseradish peroxidase 
for 5 minutes at 25° C. Finally, coverslips were washed 
in tap water for 5 minutes, mounted with Permount 
(Fisher Scientific) and viewed with a BH-2 Olympus mi-
croscope (C. Squared). Immunoreactivity depending on 
the degree of brown cytoplasmic staining was evalu-
ated in the MC.
Fifty MC from each experimental condition were 
evaluated. Each MC was graded for the intensity of 
staining as follows: 0, no brown cytoplasmic stain-
ing; 1, weak, low-intensity brown cytoplasmic staining 
less than background nuclear hematoxylin staining; 2, 
moderate, medium-intensity brown cytoplasmic stain-
ing of about the same intensity as the background nu-
clear hematoxylin staining; and 3, marked, high-in-
tensity brown cytoplasmic staining overshadowing 
background nuclear hematoxylin staining.
The grade of staining for each one of the 50 cells 
was totaled for a possible maximum score of 150 per 
experimental condition. The experiments were re-
peated in triplicate and the scores were averaged. 
The results were tabulated and represented in a graph 
form.
Statistical Analysis
ELISA and immunohistochemical data were analyzed 
for statistical significance by Spearman’s rank correla-
tion and analysis of variance. Significance was set at 
the 5% level.
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